|
Cardiovascular Pharmacology
Citations 291-300 of 640 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats
- Bernhard Pilz, Erdenechimeg Shagdarsuren, Maren Wellner, Anette Fiebeler, Ralf Dechend, Petra Gratze, Silke Meiners, David L. Feldman, Randy L. Webb, Ingrid M. Garrelds, A. H. Jan Danser, Friedrich C. Luft, and Dominik N. Müller
Hypertension published August 15, 2005, doi:10.1161/01.HYP.0000179573.91016.3f
[Abstract]
- Editorial Commentaries
Noncardiovascular Illness as Barrier to Antihypertensive Treatment
- Jan A. Staessen, Lutgarde Thijs, and Willem H. Birkenhäger
Hypertension 2005;46:255-256; published online before print as doi:10.1161/01.HYP.0000172754.53463.38
[Full text]
- Editorial Commentaries
Cardiovascular Benefits of Aldosterone Receptor Antagonists: What About Potassium?
- Gordon H. Williams
Hypertension 2005;46:265-266; published online before print as doi:10.1161/01.HYP.0000174329.99569.52
[Full text]
- Original Articles
Differing Effects of Mineralocorticoid Receptor–Dependent and –Independent Potassium-Sparing Diuretics on Fibrinolytic Balance
- Ji Ma, Francisco Albornoz, Chang Yu, Daniel W. Byrne, Douglas E. Vaughan, and Nancy J. Brown
Hypertension 2005;46:313-320; published online before print as doi:10.1161/01.HYP.0000174327.53863.86
[Abstract]
[Full text]
- Scientific Contributions
Combined Angiotensin II Type 1 and Type 2 Receptor Blockade on Vascular Remodeling and Matrix Metalloproteinases in Resistance Arteries
- Pascal Brassard, Farhad Amiri, and Ernesto L. Schiffrin
Hypertension published July 25, 2005, doi:10.1161/01.HYP.0000176744.15592.7d
[Abstract]
- Editorial Commentary
Cardiovascular Benefits of Aldosterone Receptor Antagonists. What About Potassium?
- Gordon H. Williams
Hypertension published July 18, 2005, doi:10.1161/01.HYP.0000174329.99569.52
[Abstract]
- Scientific Contributions
Differing Effects of Mineralocorticoid Receptor-Dependent and -Independent Potassium-Sparing Diuretics on Fibrinolytic Balance
- Ji Ma, Francisco Albornoz, Chang Yu, Daniel W. Byrne, Douglas E. Vaughan, and Nancy J. Brown
Hypertension published July 5, 2005, doi:10.1161/01.HYP.0000174327.53863.86
[Abstract]
- Editorial Commentary
Noncardiovascular Illness as Barrier to Antihypertensive Treatment
- Jan A. Staessen, Lutgarde Thijs, and Willem H. Birkenhäger
Hypertension published July 5, 2005, doi:10.1161/01.HYP.0000172754.53463.38
[Abstract]
- Editorial Commentaries
Rapid Effects of Aldosterone: Relevant in Cardiac Ischemia?
- Martin Wehling
Hypertension 2005;46:27-28; published online before print as doi:10.1161/01.HYP.0000171161.60967.ab
[Full text]
- Original Articles
Endothelin-1 (1-31) Is an Intermediate in the Production of Endothelin-1 After Big Endothelin-1 Administration In Vivo
- Marie-Hélène Fecteau, Jean-Claude Honoré, Mirco Plante, Julie Labonté, Giles A. Rae, and Pedro D’Orléans-Juste
Hypertension 2005;46:87-92; published online before print as doi:10.1161/01.HYP.0000170460.24604.23
[Abstract]
[Full text]
|
|
